GLAXOSMITHKLINE PLC

GSK
Delayed Quote. Delayed  - 07/27 11:38:11 am
1399.2GBX -0.04%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Other Pharmaceuticals
GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. It has a portfolio of medicines in respiratory and HIV. Its Pharmaceuticals business includes Respiratory, HIV, Specialty products, and Classic and Established products. Its Vaccines business has a portfolio of over 40 pediatric, adolescent, adult, older people and travel vaccines.

Number of employees : 94 066 people.
Sales per Business
20192020
Pharmaceuticals17 554.0052%17 056.0050%
Consumer Healthcare8 995.0026.6%10 033.0029.4%
Vaccines7 157.0021.2%6 982.0020.5%
Corporate and Other Unallocated48.000.1%28.000.1%
GBP in Million
Sales per region
20192020
United States13 890.0041.2%14 556.0042.7%
Rest of World11 795.0034.9%11 379.0033.4%
Europe7 127.0021.1%7 184.0021.1%
United Kingdom942.002.8%980.002.9%
GBP in Million
Managers
Name Title
Emma N. Walmsley Chief Executive Officer & Executive Director
Iain James Mackay Chief Financial Officer & Executive Director
Jonathan Richard Symonds Non-Executive Chairman
Karenann K. Terrell Chief Digital & Technology Officer
Hal V. Barron Executive Director & Chief Scientific Officer
Jon Ellis VP & Head-Technology Business Development
Amy Altshul SVP-Legal, Research & Development
Nick Hirons Senior Vice President-Global Ethics & Compliance
Lynn Laverty Elsenhans Independent Non-Executive Director
Urs Rohner Independent Non-Executive Director
Shareholders
Name Equities %
The Vanguard Group, Inc. 138,178,000 2.75%
BlackRock Fund Advisors 131,211,690 2.61%
BlackRock Investment Management (UK) Ltd. 128,982,522 2.56%
Norges Bank Investment Management 120,993,000 2.40%
Dodge & Cox 99,377,874 1.98%
Capital Research & Management Co. (Global Investors) 85,408,294 1.70%
BlackRock Advisors (UK) Ltd. 70,095,800 1.39%
Schroder Investment Management Ltd. 67,632,198 1.34%
State Street Global Advisors Ltd. 66,693,562 1.33%
SSgA Funds Management, Inc. 52,581,000 1.05%
Company contact information
980 Great West Road
TW8 9GS Brentford, Greater London


Phone : +44 (0)20 8047 5000
Fax : +44 (0)20 8047 7807
web site : http://www.gsk.com
Markets and indexes
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, FTSE Eurotop 100, Low Carbon 100 Europe, Stoxx Europe 50, STOXX Europe 600, Stoxx Global 200, Stoxx UK 50
Stock Exchange Codes
- Bloomberg Code :  GSK:LN
- Reuters Code :  GSK.L
- Datastream Code :  GSK
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
GLAXOSMITHKLINE PLC6.03%96 813
JOHNSON & JOHNSON9.21%452 602
ROCHE HOLDING AG11.50%327 852
PFIZER, INC.13.58%234 040
NOVARTIS AG-0.17%221 954
ELI LILLY AND COMPANY44.05%221 084
ABBVIE INC.9.93%208 043
NOVO NORDISK A/S31.49%204 273
MERCK & CO., INC.-5.57%195 576
ASTRAZENECA PLC13.22%177 536
BRISTOL-MYERS SQUIBB COMPANY9.12%151 141
AMGEN INC.6.59%140 812
SANOFI11.28%129 373
GLAXOSMITHKLINE PLC4.31%96 813
ALLERGAN PLC0.97%63 659
CHUGAI PHARMACEUTICAL CO., LTD.-24.11%62 249
BAYER AG6.68%59 604
JIANGSU HENGRUI MEDICINE CO., LTD.-36.24%58 191
TAKEDA PHARMACEUTICAL COMPANY LIMITED-1.46%52 508
DAIICHI SANKYO COMPANY, LIMITED-36.17%39 204
ASTELLAS PHARMA INC.20.55%32 281
Brand Portfolio
GLAXOSMITHKLINE
GLAXOSMITHKLINE
GSK
GSK
CELLZOME
CELLZOME
CORIXA
CORIXA
DOMANTIS
DOMANTIS
GENELABS TECHNOLOGIES
GENELABS TECHNOLOGIES
GLYCOVAXYN
GLYCOVAXYN
PARODONTAX
PARODONTAX
STIEFEL
STIEFEL
TESARO
TESARO
» More brands of GlaxoSmithKline Plc